Highlights Wave Life Sciences Ltd.

Equities

WVE

SG9999014716

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
6.18 ^USD	+0.16%		-0.64%	+22.38%

May. 15	Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target	MT
May. 09	Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (WVE) WAVE LIFE SCIENCES USA Posts Q1 Revenue $12.5M, vs. Street Est of $23M	May. 09	MT
Wave Life Sciences Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency	Apr. 30	CI
Wave Life Sciences Ltd. Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing	Apr. 23	CI
WAVE Life Sciences Shares Surge After Q4 Beats Estimates	Mar. 06	MT
Wave Life Sciences Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Wave Life Sciences Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 06	CI
Earnings Flash (WVE) WAVE LIFE SCIENCES USA Reports Q4 Revenue $29.1M, vs. Street Est of $19.8M	Mar. 06	MT
Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy	Dec. 15	CI
Wave Life Sciences Ltd. Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin Deficiency	Dec. 06	CI
Wave Life Sciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Earnings Flash (WVE) WAVE LIFE SCIENCES USA Reports Q3 Revenue $49.2M, vs. Street Est of $23.4M	Nov. 09	MT
WAVE Life Sciences Submits First Clinical Trial Application for RNA Editing Candidate	23-09-06	MT
WAVE Life Sciences Submits First Clinical Trial Application for RNA Editing Candidate	23-09-06	MT
Wave Life Sciences Ltd. Announces Submission of First Clinical Trial Application for Wve-006	23-09-05	CI
Wave Life Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03	CI
Earnings Flash (WVE) WAVE LIFE SCIENCES USA Reports Q2 Revenue $22.1M, vs. Street Est of $7.9M	23-08-03	MT
Wave Life Sciences Announces Topline Results from Phase 1B/2A Focus-C9 Study of WVE-004 for C9orf72-Associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia	23-05-23	CI
Wave Life Sciences Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-03	CI
Earnings Flash (WVE) WAVE LIFE SCIENCES USA Reports Q1 Revenue $12.9M, vs. Street Est of $38.6M	23-05-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Wave Life Sciences Ltd.

Equities

WVE

SG9999014716

Highlights

Filters